Performance/Hormonal
Turkesterone
A phytoecdysteroid from Ajuga turkestanica marketed as a natural anabolic, but lacking meaningful human clinical evidence — popular on social media, not in science.
Turkesterone
A phytoecdysteroid from Ajuga turkestanica marketed as a natural anabolic, but lacking meaningful human clinical evidence — popular on social media, not in science.
22
D
evidenceCaution
riskProven Benefits
01May increase protein synthesis (in vitro evidence only)
02No androgen receptor binding (no testosterone suppression)
03Does not require post-cycle therapy
Chemical Forms
Recommended
- Third-party tested Ajuga turkestanica extract (≥10% turkesterone)
- HPLC-verified products from reputable brands
- Hydroxypropyl-β-cyclodextrin complexed forms (theoretical bioavailability)
Avoid
- Unverified brands (high adulteration rate)
- Proprietary blends with undisclosed turkesterone content
- Products without third-party testing certificates
- Cheap bulk powder (likely underdosed or mislabeled)
Expert Note
Market adulteration is severe; third-party testing essential
Protocol
Amount
500 mg - 1,000 mg
Frequency
daily
When
Split into 2-3 doses with meals
Condition-Based Dosing
Anabolic support (speculative)
500 mg/day of 10% extract (contains 50 mg turkesterone)
Higher-dose protocols (anecdotal)
800 - 1,000 mg/day of standardized extract
Safety & Limits
Upper Safe Limit
Not established; studies used 500-1,000 mg/day short-term
Cycling
Safe for continuous use
Contraindications
Pregnancy and breastfeeding (no safety data)
Known hormone-sensitive conditions (estrogen receptor beta activation)
Competitive athletes in WADA-tested sports (on Monitoring List; may become prohibited)
Concurrent use with other hormonal supplements (unknown interactions)
Minors and adolescents (no safety data in developing individuals)
Liver or kidney disease (insufficient safety data for impaired populations)
Synergies
Avoid Combining With
- ✕Evidence-based alternatives (creatine, protein, progressive overload all have vastly superior evidence)
- ✕Short half-life and poor bioavailability limit efficacy
- ✕Low withanolide/turkesterone content in commercial products
Updated 4/15/2026